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Background & objectives: Nestin is an intermediate filament protein expressed in undifferentiated
cells during the development of brain and is considered as a marker for neuroepithelial stem cells.
Expression of this protein in various CNS tumour cells suggests the possibility of existence of
tumour stem cell modulating the evolution. We carried out an immunohistochemical study to
demonstrate the expression of nestin and its co-expression with neuronal and glial intermediate
filament and correlate with the grade of malignancy.
Methods: Formalin fixed, paraffin processed sections from two human foetuses, 16 brain tumours
of both neuronal and glial lineage and two metastatic tumours were immunostained with polyclonal
antibody to nestin. Serial sections from primary brain tumours were also stained with monoclonal
antibody to neurofilament (NF) and glial fibrillary acidic protein (GFAP). Fluorescent double
labeling was carried out on four cases using laser confocal microscopy, to document co-localization
of nestin with other intermediate filaments in the tumour cells.
Results: Nestin expression was observed along the paraventricular zone of human foetuses and in
brain tumours of both glial and neuronal lineage, of both high and low grades of malignancy. In
addition, mature dysplastic spinal motor neurons adjacent to tumour and cerebellar Purkinje
cells also expressed nestin along with neurofilament.
Interpretation & conclusion: Nestin expression was noted in both low and high grade brain tumours
and dysplastic neurons and did not parallel the malignant grade of the tumour. The expression of
nestin in tumour cells and dysplastic neurons suggests aberrant expression of antigenically primitive
proteins in cells to facilitate remodelling of the cell and migration. More studies are needed to
elucidate the concept.
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During foetal development and origin and
progression of neoplasia, certain ontological cellular
events are probably shared to facilitate growth and
differentiation by temporal expression of various
cellular proteins. To account for hierarchical
expression of these genetic events, the stem cell
concept is evoked. The stem cell is considered to be
the primitive undifferentiated mother cell, capable
of continuous yet controlled cell division, self
renewal and differentiation in predetermined patterns
to form organs. Tumourigenesis, on the other hand,
is considered to be promoted by sequential mutations
regulating the biological pathways, allowing the cells
to divide unchecked evading apoptosis, respond
abnormally to various trophic factors, receive
aberrant blood supply (angiogenesis) and to migrate
to farther locations (metastasis and invasiveness).
Bailey and Cushing1 suggested that brain
tumours evolved from undifferentiated blast cell-
a  progeni tor  s tem cel l  of  varying levels  of
commitment  to  ce l l  l ineages .  There  i s
overwhelming evidence  in  haematologica l
malignancies like leukaemias, where, among the
population of leukaemic cells, only a few stem
cells  have unlimited proliferat ive potential ,
facilitating the progression of the neoplastic
process, and these cells can be fractionated and
s tudied 2,3.  S imi lar  phenomenon could  be
operational in central nervous system (CNS)
neoplasia as well. Nests of undifferentiated cells,
which normally form granule cells of cerebellum
are  cons idered  to  t ransform to  pr imi t ive ,
malignant neurectodermal tumour (PNET), the
medulloblastoma4 and radial glia which facilitate
neuronal migration, can lead to the evolution of
pilocytic astrocytomas. During the evolution of
neoplasia and tissue repair, some cellular and
molecular events are called upon to facilitate the
process. Nestin is a gene encoding a class of
intermediate filaments (IF) specific to neural stem
cell,  sharing structural homology of varying
grades with other IF, but preserving hierarchical
and sequential expression of events during the
development of brain5,6. During CNS development
the intermediate f i lament component of  the
cytoskeleton undergoes significant remodeling.
Initially nestin is expressed in CNS stem cells5
fo l lowed by  downregula t ion  and sh i f t  to
expression of  gl ial  f ibr i l lary acidic  protein
(GFAP) and neurofilament (NF) in differentiated
astrocytes and neurons respectively7,8 in addition
to peripherin and internexin in some subset of
neuronal population 9,10.  These events reflect
temporal and spatial control of intermediate
filament expression facilitating changes in shape
and migratory potential7. As the expression of
intermediate filaments is used as a marker of cell
lineage in tumour pathology, we studied the
expression of stem cell IF marker, nestin in brain
tumours and attempted to correlate with other
appropriate lineage specific IF expression, and
the grade of malignancy. As the antibody used
was specific to human foetal brain, sections from
human foetal brain were stained to confirm the
specificity of the antibody labeling.
Material & Methods
Sixteen brain tumour specimens of varying
grades of malignancy (WHO grade I - IV), and two
metastatic tumours were derived from the surgical
biopsies  submit ted to Department  of
Neuropathology, National Institute of Mental
Health & Neurosciences (NIMHANS), Bangalore
during July 2000 to December 2004 for diagnosis.
In addition, similarly processed two paraffin
blocks of human foetal brains (well preserved
human foetal brains of 14 and 24 wk of gestation
from the col lect ion of  Human Brain Tissue
Repository,  a  National  Research Facil i ty at
NIMHANS, Bangalore,  col lected fol lowing
informed consent from the parents to use the
material for research purposes and approved by the
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Institutional Ethics Committee, were also studied.
Six micron thick paraffin sections were collected
on poly L-lysine coated glass  s l ides for
immunohistochemistry.
Antibodies: (i) Rabbit polyclonal anti-human nestin,
(150 amino acid fragment of human nestin obtained
from cloned nestin cDNA from human foetal brain,
a gift from Dr Mahendra Rao, Laboratory of Nervous
System, National Institute of Ageing, NIH, Bethesda,
MD, USA, 1:5000); (ii) Neurofilament (Monoclonal,
Isotype IgG, 1:50, DAKO, USA); (iii) Glial fibrillary
acidic protein, GFAP (Monoclonal, Isotype IgG, 1:50
DAKO, USA).
The antigen retrieval was carried out by
microwaving in citrate buffer (pH 6.0) and the
sections were stained by immunoperoxidase method,
using diaminobenzidine/hydrogen peroxide (DAB/
H2O2) as the chromogen11. Slides were counterstained
with Meyer’s haematoxylin (Sigma Chemicals,
USA). One case of medulloblastoma, which was
found to contain nestin positive cells in the pilot study
was used as a positive control. Sections from a case
of gamistocytic astrocytoma for GFAP and normal
cerebellum for neurofilament were used as normal
controls, both of which exhibited strong
immunolabeling for the respective intermediate
filaments.  Identically processed sections skipping
the primary antibody in immunostaining procedure
served as negative controls.
The sections were screened for (i) numerical
density and phenotype character of tumour cells
expressing nestin/GFAP/NF and were visually graded
from 0 to +++, blind to the type of antigen labelled
and then analysed. (0- no labeling of cells ; + : 20%
of cells ; ++ : 20-50% of cells; +++ > 50% cells); (ii)
spatial co-localization of nestin with GFAP/
neurofilament in sections.
Double labeling for co-localization of nestin and
GFAP or nestin and neurofilament was carried out
in four selected tumours (medulloblastoma,
dysplastic gangliocytoma of cerebellum with
associated medulloblastoma, subependymal giant cell
astrocytoma and giant cell glioblastoma - one case
each). The rabbit polyclonal nestin antibody (1:5000)
was visualized by goat anti-rabbit secondary antibody
conjugated with fluorescein isothiocyanate (FITC)
flurochrome (1:200, green fluorescence) and
monoclonal antibodies to GFAP or NF (1:50) were
highlighted by rabbit  anti-mouse secondary
antibody conjugated with Cy 3 (1:200, red
fluorescence Sigma Chemicals, USA).  Briefly, the
sections were equilibrated in phosphate buffer saline
with 0.1 per cent triton × 100 (0.1 M PBST, pH
7.4) for 10 min. After blocking the non-specific
binding sites with 5 per cent delipidated milk
powder and bovine serum albumin (BSA) for one
hour, the sections from medulloblastoma, dysplastic
gangliocytoma of cerebellum, both tumours of
neuronal lineage were incubated with a mixture of
primary antibodies, anti-nestin (polyclonal, 1:5000)
and anti-NF (monoclonal 1:50); and subependymal
giant cell astrocytoma and giant cell glioblastoma
with a cocktail of antibodies GFAP (1:50) and nestin
(1:5000) for 48 h at 4oC. After washing in buffer
the slides were viewed under Laser confocal
scanning microscope (DMIRE)-TCS from Leica,
Germany, with laser illumination at 488 nm for
FITC and 514 nm for Cy3, respectively.  The
fluorescence emitted by the cells in the same field
(green-nestin, red-NF/GFAP) and also compound
images of co-localization by the two fluorochromes
representing different antigens, nestin-
neurofilament and nestin-GFAP expression were
recorded.
Results
The human foetal forebrains of both the ages (14
and 24 wk) revealed nestin labeling along
periventricular zones, especially the temporal horn,
while other diencephalic nuclear clusters were not
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Table. Expression profile of nestin, glial fibrillary acidic protein (GFAP) and neurofilament (NF) in CNS tumour of different grades
Case Type Age/sex WHO Location Nestin GFAP NF
no. grade
1 Pilocytic astrocyma 26/M I Brain stem +++ ++ -
2 Juvenile  pilocytic astrocytoma 12/M I Cerebellum ++ +++ -
3 Subependymal giant cell astrocytoma I Lateral ventricle +++ + +
4 Ependymoma 25/F II Right postfrontal + + -
5 Central nerocytoma 20/F II Lateral ventricle + - -
6 Dysplastic ganglioma 9/M I & IV Cerebellum DYS N - DYS
with medulloblastoma ++ M+ N+M+
7 Anaplastic astrocytoma 28/F III Left frontal lobe + ++ -
8 Anaplastic astrocytoma 33/F III Corpus collosum ++ ++ -
9 Anaplastic oligodendroglioma 43/F III Right forntal + + -
10 Desmoplastic medulloblastoma 5/M IV Cerebellum +++ - -
11 Medulloblastoma 20/M IV Cerebellum +++ +
12 Medulloblastoma (nodular) 8/F IV Cerebellum ++ - +
13 Neuroblastoma 3/M IV Spinal cord +++ + +
14 Small cell glioblastoma 62/M IV Left frontal ++ + -
15 Glioblastoma-focal anaplastic 26/M IV Left frontal +++ ++ -
oligodendroglial zones
16 Pleomorphic glioblastoma 6/M IV Left temporal ++ + -
DYS N, Dysplastic neurons; M, medulloblastoma
- Absence of labelling
labeled. The immunolabeling revealed a gradient,
with high expression in ependymal layer and
sub-ependymal progenitor cells, and gradually
receeding with increasing distance from the ventricle
(figures not shown). The metastatic epithelial tumour
cells were not labeled for nestin while the reactive
glia and adjacent neurons were stained light.
Among the tumours studied (Table), pilocytic
astrocytomas (Fig. 1A) of both juvenile and adult
type (WHO-grade I) were stained by nestin and
GFAP. The piloid cells especially those floating
in myxoid matrix of the cystic areas were strongly
labeled for nestin (Fig. 1B), while perivascular
foot processes and subpial glial cells were labeled
light and variable.  The gliotic neuropil  was
labeled lightly by nestin, but intensely by GFAP
(Fig. 1C).
In subependymal giant cell astrocytoma (Fig.
2A), majority of large ganglioid cells were strongly
labeled by nestin, the label extending along the cell
processes (Fig. 2B) while the perivascular foot
processes were not labeled. GFAP stained variably
the tumour cells, the perivascular foot processes
and gliotic neuropil. Only a few tumour cells
revealed co-labeling, strongly with nestin, GFAP
(Fig. 2C) and faintly with NF antibody (Fig. 2D)
in serial sections visualized by immunoperoxidase
technique,  suggest ing divergent  ant igenic
expression of these cells. In lobar ependymoma
and neurocytoma, both relatively differentiated
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Fig. 1. Pilocytic astrocytoma (WHO grade I), thin piloid fibres floating in pools of myxoid stroma (A). GFAP labeled the tumour
cells light and perivascular glial fibres dark (B), while nestin stained the tumour cells intensely (C). A: Haematoxyclin eosin (HE) x
240; B, C-Immunoperoxidase x 240.
benign tumours, nestin labeled cells lightly and
they were randomly distributed and close to
vessels.
In anaplast ic  astrocytoma and
oligoastrocytoma (Fig. 3) occasional small round
tumour cells with short process and the neuropil
around were intensely labeled by nestin (Fig. 3,
inset), which probably represented anaplastic or
primitive oligodendroglia. Large stretches of
fibrillated, GFAP labeled glial cells did not express
nestin. Segments of axonal tracts traversing across
were stained by NF antibody, but none of the
tumour cel ls  were labeled.  In small  cel l
glioblastoma, both GFAP and nestin stained small
islands of tumour cells, where the expression of
nestin was less intense in contrast to GFAP. In
cases of giant cell glioblastoma (Fig. 4) and
glioblastoma with focal  anaplast ic
oligodendroglial zones, the tumour giant cells
located essentially close to blood vessels and in
the infiltrating front were strongly labeled by
nestin and GFAP as revealed by co-localizing
fluorescence in laser  scanning confocal
microscopy (Fig. 4 A, B). Similarly, the tumour
cells floating in microcystic space in anaplastic
astrocytomas, expressed nestin strongly. GFAP on
the other hand labelled large zones, both in the
tumour around the blood vessels  and the
infiltrating front only focally, corresponding to
nestin stained areas. This is in contrast to diffuse
labeling observed in low grade astrocytomas.
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Fig. 2. Subependymal giant cell astrocytoma (WHO grade I) - many large gangliod cells in a fibrillated glial stroma (A). The
gangliod cells are labeled  intensely with nestin (B) and express GFAP (C) and neurofilament (D) variably. A: HE x 240; B, C, D-
Immunoperoxidase x 480.
In medulloblastomas (Fig. 5A), large areas of
tumour cells were stained by nestin. In Homer-
Wright rosettes both the cells and the central
fibrillated zones were labeled by nestin, reflecting
the primitive nature (Fig. 5A, inset). On confocal
microscopy, the nestin labeling was found to be
more intense in the primitive tumour cells than NF,
but co-localizing reflecting dual expression (Fig.
5 B, C, D). In nodular zones, the margin of the
nodules had many nestin positive cells, suggesting
the presence of primitive cells in the spreading
front. GFAP failed to label the centrally located
pale cells in the nodular areas in medulloblastoma,
but a few cells stained with NF.
In one case of dysplastic gangliocytoma with
co-existing medulloblastoma, (Fig. 6A) a band of
pale, large, dysplastic ganglion cells occupied the
molecular layer of cerebellar folium, depleting the
small granular neurons.  Medulloblastoma, a PNET,
was found infiltrating the folia and spreading along
the surface. Majority of the large dysplastic pale
neurons  were strongly labeled by nestin and NF
(Fig. 6B, C). Co-expression of nestin/NF was noted
in a few mature neurons. The islands of
medulloblastoma were focally labeled by nestin and
NF, but not by GFAP, while GFAP labeling was
noted in reactive astrocytes and gliotic zones. The
reactive astrocytes were found labeled by nestin in
7 of the 17 tumours examined, representing
heterogeneity in the degree of differentiation of the
cell population.  In addition to tumour cells and
dysplastic neurons, a few of the cerebellar Purkinje
cells and anterior horn cells of the spinal cord
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Fig. 3. Anaplastic oligodendroglioma (WHO grade III) with
chicken wire vascular channels and anaplastic tumour cells. HE
x 240. Inset: Cytoplasmic labeling of tumour cells by nestin.
Immunoperoxidase x 300.
Fig. 4. A Giant cell glioblastomas (WHO grade IV) with
numerous pleomorphic tumour giant cells adjacent to zone of
necrosis. HEx240B. B-D. Tumour giant cell labeled for nestin
(greenish yellow-FITC channel) and GFAP (Reddish-CY3
channel/and co-expression (yellow-orange) for nestin and GFAP
respectively (Bar 75 µm).
distant to the primitive neuroectodermal tumour
expressed nestin co-localizing with NF (Fig. 7 A,
B), suggesting aberrant expression of stem cell
related IF in mature cells.
Fourteen of the 18 tumours analysed had nestin
labeling of capillary endothelial cells. Nestin
immunoreactivity was most intense in proliferating
endothelial glomeruli of malignant glioma (Fig. 8),
found in both the tumour and adjacent normal brain.
A few of the capillaries in the tumour and
endothelium lining thick hyalinized large vessels
were nestin negative, suggesting differential
expression.  In fragments of normal brain resected
along with tumour, NF expressing neurons and GFAP
expressing glia, were observed, but none were nestin
positive, except for the capillary endothelium widely.
Discussion
In mammalian nervous system subependymal
cells lining the ventricles were identified as stem cells
with an ability to generate new neurons and also
proliferate and migrate in response to injury and to
differentiate to glial lineage at the site of the
lesion12,13. In the human embryo, vimetin and nestin
expression was restricted to primitive neuroepithelial
cells and radial glial cells of spinal cord at 6-11 wk
of gestation and the ependyma and germinal matrix
of the telencephalic walls at 17-20 wk of gestation14,
similar to labeling feature noted in the present study.
The immunolabeling showed a gradient with high
expression in ependymal cells and subventricular
progenitor cells and gradually receding with
increasing distance from the ventricular wall, similar
to earlier studies14. We did not detect GFAP in the
telencephalic wall. This indicates the ontogenic and
spatial regulation of the stem cell associated
intermediate filament, nestin expression in human
foetal brain.
Among the tumours, in pilocytic astrocytomas,
the piloid cells, especially those floating in the
myxoid matrix of the cystic zones were strongly
labeled for nestin, while the perivascular foot
processes, subpial  glial cells, and piloid tumour cells
in compact zones labeled light and variable,
indicating their origin from radial glial population.
Frisen et al16 have observed that astrocytes showed
high levels of nestin when grown at low cellular
density and a weaker nestin immunoreactivity with
increased cell density causing crowding. Similar
feature is reflected by the strong labeling for nestin
in the cells floating in cystic spaces, and low level
of labeling in the compact zones. This variable nestin
expression modulated by cell density could indicate
remodeling of cytoskeletal framework to facilitate
migration and self-renewal. The quiescent gliotic
neuropil was labeled light by nestin, while reactive
astrocytes were stained moderately strong both by
nestin and GFAP reflecting transient shift in the
intermediate filament expression to ontologically
early phase in response to proximate tumour/injury.
Contrary to the observations and inferences of
Almiquist et al17, the number of piloid cells labeled
strong in our study were high, thus not correlating
with the degree of malignancy.
The subependymal giant cell astrocytoma
(SEGA), though considered hamartomatous in origin,
276 INDIAN J MED RES, SEPTEMBER 2006
Fig. 5. Medulloblastoma (WHO grade IV) with central Homer-Wright rosette. HEx300. Inset: Nestin labeling of the primitive
tumour cells and fibrillary zone within the rosette. Immunoperoxidase x 300. Laser confocal labeling of tumour cells B-Nestin
(Greenish yellow, FITC), C- Neurofilament (Red-CY3), D-colocalisation of nestin and NF in tumour cells. (Bar 18.75 µm).
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Fig. 6. Gangliocytoma of cerebellum (WHO grade I) widening the cerebellar folia by large abnormal dysplastic neurons occupying
the molecular layer and depleting the internal granular layer and co-existing medulloblastoma above (WHO grade IV) (A) Antibody
to neurofilament (B) labeled the large dysplastic neurons and its processes. Nestin (C) co-labelled the large dysplastic neuronal
soma and a few medulloblastoma cells on the surface. A: HE x 240; B - Immunoperoxidase x 150; C Immunoperoxidase x 350.
ganglioid. The persistence of bipotential (neuronal
and glial) expression of IF protein reflects aberrant
differentiation of the cell lineage. The cells in
intermediate grade neoplasms (WHO grade II), the
ependymoma  and neurocytoma, one of glial and the
other neuronal lineage expressed nestin in small focal
areas, indicating persistence of cells of stem cell
potential. The cells expressing nestin,
morphologically were small, with globular cell soma
is now recognized to be a benign tumour, the tumour
cells having a potential to express dual lineage of
IFs, both neuronal and glial, in the same cell. In the
present case under study, majority of the cells in
SEGA expressed nestin of varying intensity, while
nearly one fifth of cells in the lesion expressed
neurofilament and GFAP. The expression of nestin
in majority though suggests relatively primitive
stage, the phenotypic features of the cells were
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and small, stubby processes, resembling Golgi type
II neurons or oligodendroglia in Golgi silver staining
as also reported by others17,18 on ependymomas.
In the present study, case 6 had a dysplastic
gangliocytoma of cerebellum, the large dysplastic
neurons expressing nestin in the cell soma and co-
localized with neurofilament. Unusually this case
also had a co-existing medulloblastoma, a PNET of
cerebellum, focally expressing nestin and NF. This
case demonstrated the persistence of stem cell
marker, both in primitive tumour cells and mature
neurons as a continuum. This lends support to the
hypothesis that focal cortical dysplasia is not just
arrested neuronal migration, but also failure of
maturation and hierarchical intermediate filament
shift to early stages19. This accounts for the round
ballooned nature of dysplastic neurons with absent
or stunted dendritic arborisation. The expression of
nestin and phosphorylated NF in cerebellar Purkinje
cells and spinal motor neurons away from the
neoplastic zone reflects reactivation of
developmental programme in mature neurons for
survival under pathological conditions, as suggested
in cases of Creutzfeldt-Jakob disease20.
The malignant glial neoplasms, anaplastic
astrocytomas and glioblastomas expressed nestin in
variable number of tumour cells, especially close
to vessels present as clusters or randomly
distributed. In medulloblastoma especially in the
nodular and desmoplastic zones, expression of
nestin along the margin of the nodular areas and in
inter-nodular zones, suggests centrifugal spread of
stem cells along the advancing front, the central area
having differentiated cells.  The anaplastic
astrocytoma and glioblastoma had cells expressing
both nestin and GFAP and negative for NF,
indicating the presence of only glial progenitor cell.
The percentage of nestin positive cells in
medulloblastoma and glioblastoma are essentially
similar to those in benign subependymal giant cell
astrocytoma. This observation highlighted two
features. (i) Nestin expressing stem cells/progenitor
cells do exist both in low and high grade tumour as
clonal clusters or randomly distributed, (ii) Nestin
Fig. 7. Laser confocal microscopy. A-spinal motor neurons, (37.5 mm) B-cerebellar Purkinje cells (Bar 18.75mm) away from the
lesion in a case of ganglioglioma. 1. Nestin (yellow-green-FITC channel); 2. Neurofilament (Red CY3 channel); and 3. Co-localization
of nestin and NF (yellow-orange) channel.
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expression does not run parallel to the malignant
grade of the tumour.
These results are in contrast to the earlier
observations14,17 though the cause is not evident. The
mature oligodendroglial component and anaplastic
cells, both expressed nestin, though of different
degrees, indicating preservation of foetal characters
in the tumours cells.
The expression of nestin in neoplastic cells, the
reactive astrocytes, normal cerebellar Purkinje cells
and spinal motor neurons adjacent to the neoplastic
lesion and dysplastic neurons, address different
issues. In the scar tissue and the edge of the
pathological lesion, the cells revert ontogenically
expressing nestin to facilitate remodeling of
cytoskeletal framework of the cells, thus facilitating
migration and remodeling of the injured area12. On
the contrary, the potential of a progenitor cell, nestin
expression in neoplastic cells probably facilitate self
renewal and migration along the interstitial space to
reach the vessels. This multipotent progenitor
character is further exemplified by the new group of
glioneuronal tumours recognized recently expressing
both the phenotypes of glia and neurons21. In
dysplastic neurons, nestin expression could be an
aberrant event or failure of “switching off” the
hierarchically early forms of cytoskeletal protein.
The ubiquitous expression of nestin in the
vascular endothelium either normal or glomeruloid
structures in glioblastoma multiforme (GBM)
probably refers to perpetual self renewal potential
which is probably essential to replenish the
endothelial cells subjected to continuous shearing
haemodynamic flow and facilitate neurogenesis from
stem cells as well22. This may not be a reflection of
neoplasia.
The definitive evidence for the concept of tumour
stem cell is identifying the clones of premature cells
and demonstrating their in vitro tumourogenesis.
Singh et al23 have evolved primary tumour sphere
cultures and isolated ‘CD-133 expressing stem cell
population’. These cells in culture transformed to
tumour cells, phenotypically resembling the parent
tumour in the patient. It seems that normal stem cells
in the nervous system and cancer cells share similar
phenotype and functional properties, yet differing in
some unique molecular mechanisms to take divergent
pathways. More studies are needed to further
elucidate the concept and the biology of tumour stem
cells.
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